Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
-
menu_book
This study evaluated histological pattern of residual tumour in patients who received neoadjuvant chemotherapy (NACT) in order to determine whether this affected oncological outcomes. The study cohort...
Alison Laws MD et al | Annals of Surgical Oncology
09.07.2022 | Added: 09.07.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Recurrence
menu_bookPublication menu_book -
desktop_windows
Alexandra Zaborowski | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Axilla
desktop_windowsWebcast desktop_windows -
desktop_windows
Systemic Therapy during pregnancy and in the postpartum
Anne Armstrong | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Systemic therapy Pregnancy Associated Breast Cancer/ PABC
desktop_windowsWebcast desktop_windows -
desktop_windows
Samantha Nimalesena | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Pregnancy Associated Breast Cancer/ PABC Radiotherapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Iain MacPherson | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Trials
desktop_windowsWebcast desktop_windows -
desktop_windows
Compliance with adjuvant endocrine therapy and management of side effects
Ann Partridge | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Supporting women with adherence to endocrine therapy
Linda Sharp & Eila Watson | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Peter Schmid | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Immunotherapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Stuart McIntosh | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Oncology - Latest guidance (NACT)
Prof Carlo Palmieri | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Imaging - Latest guidance (NACT)
Sarah Vinnicombe | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Adjuvant radiotherapy post NACT
Andreas Makris | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Surgery - Latest guidance (NACT)
Tracey Irvine | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Breast conservation after neo-adjuvant chemotherapy for triple negative breast cancer
Stephanie Wong | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Andrew Tutt | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: PARP inhibitors
desktop_windowsWebcast desktop_windows -
desktop_windows
Indrani Battacharya | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Katie Miller | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy
desktop_windowsWebcast desktop_windows -
menu_book
Radiotherapy omission is considered in women >70 years old with ER+ T1N0 tumour post-BCS if the patient receives endocrine therapy (ET). However, the impact of poor adherence to ET on locoregional rec...
Regina Matar MD et al | Annals of Surgical Oncology
24.04.2022 | Added: 24.04.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy Management of the older patient
menu_bookPublication menu_book
